Profiel
Christopher L.
Lehman worked as a Chief Financial Officer at Eureka Therapeutics, Inc. from 2018 to 2019, and at Avellino Labs USA, Inc. from 2019 to 2020.
He also worked as a Vice President-Financial Strategy at Coherus BioSciences, Inc. from 2013 to 2017, and as a Chief Financial Officer at RenovoRx, Inc.
Eerdere bekende functies van Christopher L. Lehman
| Bedrijven | Functie | Einde |
|---|---|---|
| RENOVORX, INC. | Director of Finance/CFO | 15-07-2022 |
Avellino Labs USA, Inc.
 Avellino Labs USA, Inc. Medical/Nursing ServicesHealth Services Avellino Lab USA, Inc. engages in the provision of diagnostic testing services. It focuses on developing genetic tests for eye care professionals. It also involves in research and development activities related to genetic diagnostics for the prediction and prevention of eye conditions. The company was founded by Gene Lee in 2008 and is headquartered in Menlo Park, CA. | Director of Finance/CFO | 01-08-2020 |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Director of Finance/CFO | 01-01-2019 |
| COHERUS BIOSCIENCES, INC. | Corporate Officer/Principal | 01-06-2017 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| RENOVORX, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. BiotechnologyHealth Technology Eureka Therapeutics, Inc. develops therapeutic monoclonal antibodies for cancer indication and treatment. It focuses on the discovery of fully-human antibody drugs for the treatment of cancer and utilizing its antibody drug discovery and engineering technologies, and advancing therapies for targeting previously inaccessible cancer antigens. The company was founded by Cheng Liu in 2006 and is headquartered in Emeryville, CA. | Health Technology |
Avellino Labs USA, Inc.
Avellino Labs USA, Inc. Medical/Nursing ServicesHealth Services Avellino Lab USA, Inc. engages in the provision of diagnostic testing services. It focuses on developing genetic tests for eye care professionals. It also involves in research and development activities related to genetic diagnostics for the prediction and prevention of eye conditions. The company was founded by Gene Lee in 2008 and is headquartered in Menlo Park, CA. | Health Services |
